What is uterine serous adenocarcinoma?
Uterine serous adenocarcinoma (USC) is rare and invasive cancer. This cancer is more often reported in the ovary, the fallopian tube, and the endometrium than uterine cervix. No matter where the tumor is located, the tumor exhibits similar histological characteristics.
What is the survival rate of serous carcinoma?
Uterine serous carcinoma (USC) accounts for 10% of all endometrial cancer; however, it carries the poorest prognosis, with 5-year survival rates as low as 55% [13].
Is serous carcinoma curable?
Is high grade serous ovarian carcinoma curable? Patients with HGSOC often respond well to treatment, and can experience remission — however, it is common for high grade serous patients to recur over a period of time, with the majority of recurrences occurring within three years.
Where does uterine serous carcinoma spread?
Background: Uterine papillary serous carcinoma (UPSC) is a highly malignant form of endometrial cancer with a high propensity for metastases and recurrences even when there is minimal or no myometrial invasion. It usually metastasizes to the pelvis, retroperitoneal lymph nodes, upper abdomen, and peritoneum.
What causes serous adenocarcinoma?
Uterine serous carcinoma is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy, prompted by post-menopausal bleeding.
What is serous cancer?
Serous carcinoma is a type of cancer that traces its origins to serous fluid, or serum. This is a bodily fluid that is transparent and yellowish, and it is also known as blood serum since it is separated as a liquid substance from blood when it is clotted.
What does cystadenocarcinoma, serous mean?
Cystadenocarcinoma, Serous. A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences.
What is uterine serous carcinoma?
Uterine serous carcinoma. Uterine serous carcinoma (USC), is an uncommon form of endometrial cancer that typically arises in postmenopausal women.